Michael Kuehn

Vice President
Michael Kuehn

New York


Dipl. Kaufmann (M.B.A. equivalent) and Staatsexamen (pharmacy degree), University of the Saarland; Pharmacist License

Summary of Experience

Mr. Kuehn is an experienced value strategy consultant in the health care sector. He has spent over 15 years supporting large pharmaceutical, biotech, and early-stage companies with market access, reimbursement, and pricing strategy based on meaningful value propositions and decision-relevant evidence. Mr. Kuehn’s expertise includes early market access and pricing assessments, payer value propositions, and payer-rationalized clinical trial design. He is also well versed in more tactical market access and pricing launch strategy with US and global geographic scopes.

Mr. Kuehn’s work primarily covers oncology, inflammatory diseases, and other specialty therapeutic areas. In particular, he focuses on translating scientific evidence into relatable information for decision makers in market access and pricing. Recent project examples include developing the launch pricing strategy for a biosimilar in the inflammatory space, developing the value and market access launch strategy for an oral product in the inflammatory area, and assessing the payer landscape for a novel oncology therapy. In his publications, Mr. Kuehn has covered a range of market access and pricing topics. These include US market entry hurdles for biosimilars and the development of value frameworks in the US.